Logo image of CHR-DB-B.CA

CHORUS AVIATION INC (CHR-DB-B.CA) Stock Fundamental Analysis

TSX:CHR-DB-B - CA17040TAE25

100.75 CAD
+0.55 (+0.55%)
Last: 8/14/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, CHR-DB-B scores 4 out of 10 in our fundamental rating. CHR-DB-B was compared to 8 industry peers in the Passenger Airlines industry. CHR-DB-B has an average financial health and profitability rating. CHR-DB-B does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CHR-DB-B had positive earnings in the past year.
In the past year CHR-DB-B had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CHR-DB-B reported negative net income in multiple years.
In the past 5 years CHR-DB-B always reported a positive cash flow from operatings.
CHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.91%, CHR-DB-B is doing worse than 62.50% of the companies in the same industry.
CHR-DB-B's Return On Equity of -4.82% is on the low side compared to the rest of the industry. CHR-DB-B is outperformed by 62.50% of its industry peers.
With an excellent Return On Invested Capital value of 6.54%, CHR-DB-B belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CHR-DB-B is in line with the industry average of 5.44%.
The 3 year average ROIC (5.30%) for CHR-DB-B is below the current ROIC(6.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROIC 6.54%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR-DB-B.CA Yearly ROA, ROE, ROICCHR-DB-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

With a Operating Margin value of 6.87%, CHR-DB-B perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CHR-DB-B has declined.
Looking at the Gross Margin, with a value of 65.48%, CHR-DB-B belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
In the last couple of years the Gross Margin of CHR-DB-B has declined.
Industry RankSector Rank
OM 6.87%
PM (TTM) N/A
GM 65.48%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR-DB-B.CA Yearly Profit, Operating, Gross MarginsCHR-DB-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHR-DB-B is destroying value.
CHR-DB-B has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHR-DB-B has more shares outstanding
Compared to 1 year ago, CHR-DB-B has an improved debt to assets ratio.
CHR-DB-B.CA Yearly Shares OutstandingCHR-DB-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR-DB-B.CA Yearly Total Debt VS Total AssetsCHR-DB-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CHR-DB-B has an Altman-Z score of 2.39. This is not the best score and indicates that CHR-DB-B is in the grey zone with still only limited risk for bankruptcy at the moment.
CHR-DB-B's Altman-Z score of 2.39 is amongst the best of the industry. CHR-DB-B outperforms 87.50% of its industry peers.
CHR-DB-B has a debt to FCF ratio of 7.89. This is a slightly negative value and a sign of low solvency as CHR-DB-B would need 7.89 years to pay back of all of its debts.
The Debt to FCF ratio of CHR-DB-B (7.89) is better than 87.50% of its industry peers.
CHR-DB-B has a Debt/Equity ratio of 0.54. This is a neutral value indicating CHR-DB-B is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.54, CHR-DB-B is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Altman-Z 2.39
ROIC/WACC0.74
WACC8.89%
CHR-DB-B.CA Yearly LT Debt VS Equity VS FCFCHR-DB-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.14 indicates that CHR-DB-B should not have too much problems paying its short term obligations.
CHR-DB-B has a Current ratio (1.14) which is in line with its industry peers.
A Quick Ratio of 0.61 indicates that CHR-DB-B may have some problems paying its short term obligations.
CHR-DB-B has a worse Quick ratio (0.61) than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.61
CHR-DB-B.CA Yearly Current Assets VS Current LiabilitesCHR-DB-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 78.57% over the past year.
Measured over the past years, CHR-DB-B shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.03% on average per year.
The Revenue for CHR-DB-B has decreased by -13.36% in the past year. This is quite bad
CHR-DB-B shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.56% yearly.
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%

3.2 Future

Based on estimates for the next years, CHR-DB-B will show a small growth in Earnings Per Share. The EPS will grow by 1.21% on average per year.
Based on estimates for the next years, CHR-DB-B will show a decrease in Revenue. The Revenue will decrease by -5.14% on average per year.
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHR-DB-B.CA Yearly Revenue VS EstimatesCHR-DB-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR-DB-B.CA Yearly EPS VS EstimatesCHR-DB-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 44.78, the valuation of CHR-DB-B can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CHR-DB-B indicates a slightly more expensive valuation: CHR-DB-B is more expensive than 62.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.90, CHR-DB-B is valued quite expensively.
The Price/Forward Earnings ratio is 52.27, which means the current valuation is very expensive for CHR-DB-B.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CHR-DB-B indicates a slightly more expensive valuation: CHR-DB-B is more expensive than 62.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.52, CHR-DB-B is valued quite expensively.
Industry RankSector Rank
PE 44.78
Fwd PE 52.27
CHR-DB-B.CA Price Earnings VS Forward Price EarningsCHR-DB-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHR-DB-B indicates a slightly more expensive valuation: CHR-DB-B is more expensive than 62.50% of the companies listed in the same industry.
CHR-DB-B's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHR-DB-B is cheaper than 62.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 53.24
EV/EBITDA 13.73
CHR-DB-B.CA Per share dataCHR-DB-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y12.98%
EPS Next 3Y1.21%

2

5. Dividend

5.1 Amount

CHR-DB-B has a Yearly Dividend Yield of 1.60%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.83, CHR-DB-B pays a bit more dividend than its industry peers.
Compared to the average S&P500 Dividend Yield of 2.32, CHR-DB-B is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.6%

5.2 History

The dividend of CHR-DB-B is nicely growing with an annual growth rate of 21.58%!
CHR-DB-B is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of CHR-DB-B are negative and hence is the payout ratio. CHR-DB-B will probably not be able to sustain this dividend level.
CHR-DB-B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-34.57%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
CHR-DB-B.CA Yearly Income VS Free CF VS DividendCHR-DB-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR-DB-B (8/14/2025, 7:00:00 PM)

100.75

+0.55 (+0.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners2.5%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap2.59B
Analysts78.18
Price Target133.9 (32.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.6%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-34.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.45%
Min EPS beat(2)3.87%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)3.87%
Max EPS beat(4)207.96%
EPS beat(8)5
Avg EPS beat(8)11.1%
EPS beat(12)6
Avg EPS beat(12)4.98%
EPS beat(16)8
Avg EPS beat(16)3.11%
Revenue beat(2)0
Avg Revenue beat(2)-6.13%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-3.95%
Revenue beat(4)0
Avg Revenue beat(4)-6%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-2.48%
Revenue beat(12)5
Avg Revenue beat(12)-1.45%
Revenue beat(16)8
Avg Revenue beat(16)1.16%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-4.66%
EPS NQ rev (3m)2.05%
EPS NY rev (1m)-4.29%
EPS NY rev (3m)1.77%
Revenue NQ rev (1m)-1.98%
Revenue NQ rev (3m)-2.45%
Revenue NY rev (1m)-2.63%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE 44.78
Fwd PE 52.27
P/S 1.9
P/FCF 53.24
P/OCF 30.65
P/B 4.83
P/tB 4.91
EV/EBITDA 13.73
EPS(TTM)2.25
EY2.23%
EPS(NY)1.93
Fwd EY1.91%
FCF(TTM)1.89
FCFY1.88%
OCF(TTM)3.29
OCFY3.26%
SpS53.16
BVpS20.88
TBVpS20.54
PEG (NY)0.81
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROCE 8.82%
ROIC 6.54%
ROICexc 6.9%
ROICexgc 6.96%
OM 6.87%
PM (TTM) N/A
GM 65.48%
FCFM 3.56%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Debt/EBITDA 1.36
Cap/Depr 30.21%
Cap/Sales 2.62%
Interest Coverage 2.06
Cash Conversion 39.75%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.61
Altman-Z 2.39
F-Score5
WACC8.89%
ROIC/WACC0.74
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A
EBIT growth 1Y-53.02%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year88.24%
EBIT Next 3Y15.21%
EBIT Next 5YN/A
FCF growth 1Y-79.47%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-70.44%
OCF growth 3Y12.73%
OCF growth 5Y0.25%